Limba
|
Selitrectinib (LOXO-195, BAY 2731954) is an orally available, highly potent, and selective TRK kinaseinhibitor with low nanomolar inhibitory activity against TRKA G595R, TRKC G623R, and TRKA G667C, IC50s ranging from 2.0 to 9.8 nmol/L. It is more than 1,000-fold selective for 98% of non-TRK kinases tested.
Price | 1.262,00 RON (preturile sunt fara TVA) |
---|---|
Description |
Selitrectinib (LOXO-195, BAY 2731954) is an orally available, highly potent, and selective TRK kinaseinhibitor with low nanomolar inhibitory activity against TRKA G595R, TRKC G623R, and TRKA G667C, IC50s ranging from 2.0 to 9.8 nmol/L. It is more than 1,000-fold selective for 98% of non-TRK kinases tested. |